Showing results (51-60 of 721) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|December 1, 2022
CAR T-cell therapies in China: rapid evolution and a bright futureYongxian Hu, Jingjing Feng, Tianning Gu, et al.
The Lancet. Haematology|July 1, 2022
[18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trialAbby Douglas, Karin Thursky, Timothy Spelman, et al.
The Lancet. Haematology|November 1, 2019
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort studyEffie W Petersdorf, Mary Carrington, Colm O'hUigin, et al.
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
The Lancet. Haematology|July 30, 2021
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 studyRyan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
The Lancet. Haematology|July 30, 2021
Improving the investigative approach to polycythaemia vera: a critical assessment of current evidence and vision for the futureLukas Ronner, Sangeetha Venugopal, Erin Moshier, et al.
The Lancet. Haematology|August 30, 2016
Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trialAlhossain A Khalafallah, Carl Yan, Raghad Al-Badri, et al.
The Lancet. Haematology|August 30, 2016
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trialHannah Cohen, Beverley J Hunt, Maria Efthymiou, et al.
The Lancet. Haematology|October 14, 2018
Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysisElham E Amin, Arina J Ten Cate-Hoek, Annemieke C Bouman, et al.
The Lancet. Haematology|April 15, 2019
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical studyFrancesca Ferrua, Maria Pia Cicalese, Stefania Galimberti, et al.
Pageof 73